Poster Presentations: Wednesday, November 3, 2010 |

Anemia in COPD and Related Factors FREE TO VIEW

Ali Fidan, MD; Muharrem Tokmak, MD; Nesrin Kiral, MD; Sevda S. Comert, MD; Gulsen Sarac, MD; Banu Salepci, MD; Benan Caglayan, MD
Author and Funding Information

Dr. Lutfi Kirdar Kartal Education and Research Hospital Department of Chest Dis, Istanbul, Turkey

Chest. 2010;138(4_MeetingAbstracts):457A. doi:10.1378/chest.10779
Text Size: A A A
Published online


PURPOSE: To determine frequency of anemia in COPD and its relations to the concomitant diseases, dyspnea status and severity of COPD.

METHODS: In 2008, 102 COPD patients in out-patient clinic were included prospectively. Age, gender, concomitant diseases, BMI, x-ray findings and smoking history were recorded. PFTs, WBC count test and MRC dyspnea scorrings were performed. Anemic ( WHO classification) patients were evaluated, anemia without spesific etiology was considered COPD-related-anemia. Chi-squre and Mann-Whitney U tests were used in statistical analysis.

RESULTS: Mean age of 98(96.1%) male and 4(3.9%) female patients was 61.8±10.9. Mean Hb:14.2±1.9 g/dl and mean Htc:35.1% was found. Mean FEV1(%pred) was 55.3±19.0 and FEV1/FVC was 51.1±11.0. Of cases, 47(46.1%) had concomitant disease(s) and hypertension was the leading (n=26, 25.5%) followed by coronary artery disease (n=18, 17.6%). Anemia (Htc< 36% for female, Htc< 39% for male) was found in 20(19.6%) patiens, of which 14(70%) were attributed to COPD after further evaluation. Iron deficiency (n=3) and active bleeding (n=3) were other anemia causes . Anemia was found in 27.6% and 12.7% cases with and without concomitant disease(s) respectively (p=0.048). COPD patients with hypertension had significantly more anemia than patients without hypertension. (34.6% vs. 14.4%, p=0.026). COPD stage-3,4 (GOLD stages) patiens had more frequent anemia (21.4%) compared to stage-1,2 (18.3%) without statistical significance. Also more dyspneic MRC scale 2-4 patients had more anemia (24.4%) compared to MRC scale 0-1 (15.0%) patients without statistical significance. COPD-related-anemia rates were gradually increasing as COPD severity increases from stage-1 to stage-4 (0%, 54.5%, 87.5% and 100%, respectively). COPD-related anemia rate was higher in COPD stage-3,4 (88.8%) when compared to COPD stage-1,2 (54.5%) (p=0.095). Policytemia was found in 5(4.9%) patients. There was no relation between anemia and spirometric values, chest x-ray findings, BMI, age and gender.

CONCLUSION: Anemia in COPD is unexpectedly frequent. Although concomitant diseases are related with anemia, COPD itself may cause anemia especially as the disease gets worse regarding COPD stages.

CLINICAL IMPLICATIONS: Anemia in addition to policytemia should be a part of evaluation of COPD patient.

DISCLOSURE: Ali Fidan, No Financial Disclosure Information; No Product/Research Disclosure Information

12:45 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543